Beta
Today
Operations & Footprint 8 Oct 2026

Ritedose opens USD 17m cGMP laboratory in South Carolina

The Ritedose Corporation has opened a current Good Manufacturing Practice laboratory at its Performance Park site in South Carolina, an investment of more than USD 17m. The facility triples the contract manufacturer's analytical chemistry and microbiology footprint and adds a stability programme with 10 qualified ICH chambers.

Why this mattersTripling analytical chemistry and microbiology capacity lets Ritedose run stability programmes in-house, supporting pharmaceutical customers from development to launch without outsourcing testing.

  • Investment in the new cGMP laboratory exceeds USD 17m
  • The laboratory triples Ritedose's analytical chemistry and microbiology footprint
  • It occupies the newest building at Ritedose Performance Park in South Carolina
  • The stability programme has 10 qualified ICH chambers covering long-term, accelerated, intermediate, refrigerated and controlled room temperature studies
  • The laboratory also supports freeze-thaw and photostability testing
Ritedose
Sources contractpharma.com
Relevant to you?

Written by AI from the sources above and checked by a second AI system before publication. No human wrote or edited this story. How it is made.

Updates

  • 2026-10-09 · Edited before publication: Dollar amounts were written as '$17m' rather than USD, a style failure. Materiality reduced to 2: a laboratory expansion at a contract manufacturer adds testing capability, not packaging capacity.